系统性硬化症患者认知功能受损的危险因素
Luca Krampek1, Franciska Kiss2, Nelli Farkas3
1Department of Rheumatology and Immunology, Medical School, University of Pécs; and Saint Andrew Hospital for Rheumatic Diseases, Hévíz, Hungary.
Clinical and experimental rheumatology
|August 4, 2025
概括
系统性硬化症患者.
科学领域:
- 风湿病学和神经病学
- 系统性硬化症研究研究
- 神经科学是一个神经科学.
背景情况:
- 系统性硬化症 (SSc) 是一种由广泛的血管病变和纤维化所标志的疾病.
- 认知障碍,影响注意力,记忆力和复杂任务的表现,可以发生在SSc患者.
- 之前的研究指出了大脑的微血管变化,但缺乏对SSc相关认知症状的全面调查.
研究的目的:
- 研究系统性硬化症患者的认知功能和详细的临床参数之间的关系.
- 确定影响SSc认知表现的特定因素.
主要方法:
- 一项涉及160名SSc患者和62名健康对照者的研究,进行了12个月的跟踪.
- 在基线和随访期间进行了神经心理测试,包括MMSE,Digit Span,Trail Making A/B和Digit Symbol.
- 分析了临床数据,包括人口统计和疾病严重程度.
主要成果:
- 认知障碍在早期或严重的扩散皮肤SSc.中没有明显的表现.
- 认知分数独立地与年龄,教育,疼痛,就业,高血压,血红蛋白,心脏功能和肌肉力量有关.
- 六分钟步行距离 (6MWT) 的变化与一年内MMSE分数的变化相关.
结论:
- 除了一般的认知因素 (年龄,教育,就业,高血压,疼痛) 外,SSc认知功能受心血管功能 (透支功能障碍),血红蛋白水平和肌肉力量降低的影响.
- 通过使用6MWT,可以有效评估SSc中的心血管状况和肌肉状况.
相关概念视频
Coronary Artery Disease I: Introduction
57
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
57
Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62
Negative and Cognitive Symptoms of Schizophrenia
125
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
125
Psychological and Sociocultural Causes of Schizophrenia
189
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
189
Factors Affecting Illness
4.4K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.4K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
114
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
114


